liver cancer
Conditions
Interventions
Guided Intervention Group:Timely medical guidance
motivation Group:expense deduction
Guide and Motivation:Timely medical guidance and enpense deduction
Knowledge Education Intervention Group:Knowledge Education
Clinical Decision Support System Intervention Group:SURVEILLANCE Surveillance Sodule
Evaluate Feedback Intervention:Rank and Feedback Liver Cancer Surveillance Satus
Risk population control group:Regularly participate in medical activities
Medical staff control group:Regularly participate in medical activities
Sponsors
The Sixth Affiliated Hospital of Dali University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Over 18 years old; the surveillance population in the voluntary enrollmentreference to the diagnostic criteria in the Diagnostic Criteria for Viral Hepatitis B (WS299-2018),Diagnostic Criteria for Viral Hepatitis C» (WS213-2018) and «Guidelines for Stratified Screening and Surveillance of Primary Liver Cancer» (2020 Edition), meeting the diagnoses of hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection diagnosis, nonalcoholic fatty liver diagnosis, cirrhosis diagnosis, and those at risk for liver cancer with a family history of liver cancer and long-term alcohol abuse or consumption of aflatoxin-contaminated food.
Exclusion criteria
Exclusion criteria: History of liver cancer; Human immunodeficiency virus (HIV) infection; Liver transplantation before the start of the study or during follow-up; Unable to cooperate with the investigation due to mental disorder.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of Time up-to-date with Surveillance;Early Diagnosis Rate of Liver Cancer;Implementation Outcome; | — |
Countries
China
Contacts
Public ContactJingyi Dai
Dali University/The Sixth Affiliated Hospital Kunming Third People's Hospital
Outcome results
None listed